凝血因子VII缺乏:对替代疗法和预防的临床影响和方法的审查
Nader Cohan1, Elham Abedi1, Mehran Karimi2
1Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Pediatric blood & cancer
|June 26, 2025
概括
第七因子 (FVII) 缺乏症是一种罕见的出血乱,具有多种症状. 管理需要个性化治疗,包括替代疗法和严重病例的预防,以优化患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 罕见疾病 罕见疾病
背景情况:
- 第七因子 (FVII) 缺乏症是一种罕见的出血障碍,具有遗传或获得的起源.
- 在F7基因的突变导致遗传FVII缺陷,导致不同的临床表现,从无症状到严重的出血.
- 症状严重程度通常与血FVII水平无关.
研究的目的:
- 对因子VII缺乏症的当前治疗方法进行审查.
- 为了确定管理FVII缺陷的新出现的挑战.
- 强调量身定制的治疗策略对于最佳患者结果的重要性.
主要方法:
- 凝血试验包括前血时间 (PT).
- 评估FVII活动和抗原水平.
- 临床背景评估.
主要成果:
- 诊断包括凝血测试和临床评估的结合.
- 按需的替代疗法 (复合激活FVII,血衍生FVII,PCCs,FFP) 是遗传FVII缺乏症的常见疗法.
- 长期预防对于有重大出血史的严重病例至关重要.
结论:
- 管理VII因子缺乏症需要个性化治疗计划.
- 个性化策略是解决FVII缺陷异质性的关键.
- 优化患者的治疗结果取决于量身定制的治疗方法.
相关概念视频
Venous Thrombosis III: Interprofessional Care
27
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
27
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
921
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
921
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Venous Thrombosis IV: Nursing Management
27
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
27
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
41
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
41


